Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation.
Berberine (BERB) and a combination (COMB) of berberine (CAS 2086-83-1) with policosanol (CAS 557-61-9), red yeast extract (containing monacolin, CAS 557-61-9), folic acid and astaxanthin were orally administered daily for 4 weeks to 40 subjects with moderate dyslipidemias divided in two parallel groups each of 20 subjects. Total cholesterol (TC), LDL, HDL, Non HDL, ApoB, ApoA, Lp(a) and triglycerides (TG) were measured before and at the end of treatments. BERB and COMB significantly reduced TC (respectively by 16% and 20%), LDL (by 20% and 25%), ApoB (by 15% and 29%) and TG (by 22% and 26%), and increased HDL (by 6.6% and 5.1%). Adverse events or impairments of liver transaminases or of CPK were not observed. In conclusion, food supplements containing natural products such as berberine, policosanol, red yeast extracts, folic acid and astaxanthin could be a useful support to diet and life style changes to correct dyslipidemias and to reduce cardiovascular risk in subjects with moderate mixed dyslipidemias.
Cicero
Arrigo F G
AF
"G. Descovich" Atherosclerosis and Dysmetabolic Disease Research Center, "D. Campanacci" Clinical Medicine and Applied Biotechnology Department, University of Bologna, Bologna, Italy.
Rovati
Lucio C
LC
Setnikar
Ivo
I
D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001599:Berberine / Q000009:adverse effects / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D019587:Dietary Supplements; D004338:Drug Combinations; D050171:Dyslipidemias / Q000097:blood / Q000188:drug therapy*; D005233:Fatty Alcohols / Q000627:therapeutic use; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D016037:Single-Blind Method; D024341:Xanthophylls / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D004338:Drug Combinations; D005233:Fatty Alcohols; D008055:Lipids; D008074:Lipoproteins; D024341:Xanthophylls; D001599:Berberine; C080710:policosanol; C005948:astaxanthine; D005492:Folic Acid; D002784:Cholesterol